| Citation: | Branch of Organ Transplantation of Chinese Medical Association. Technical specification for clinical diagnosis and treatment of tuberculosis after organ transplantation (2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(4): 359-363. doi: 10.3969/j.issn.1674-7445.2019.04.003
|
| [1] |
GRADE working group[EB/OL]. [2018-12-20]. http://www.gradeworkinggroup.org/index.htm.
|
| [2] |
SUBRAMANIAN A, DORMAN S, AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis in solid organ transplant recipients[J]. Am J Transplant, 2009, 9 (Suppl 4): S57-S62. DOI: 10.1111/j.1600-6143.2009.02894.x.
|
| [3] |
EPSTEIN DJ, SUBRAMANIAN AK. Prevention and management of tuberculosis in solid organ transplant recipients[J]. Infect Dis Clin North Am, 2018, 32(3):703-718. DOI: 10.1016/j.idc.2018.05.002.
|
| [4] |
MAJEED A, BEATTY N, IFTIKHAR A, et al. A 20-year experience with nocardiosis in solid organ transplant (SOT) recipients in the Southwestern United States: a single-center study[J]. Transpl Infect Dis, 2018, 20(4):e12904. DOI: 10.1111/tid.12904.
|
| [5] |
HORNE DJ, NARITA M, SPITTERS CL, et al. Challenging issues in tuberculosis in solid organ transplantation[J]. Clin Infect Dis, 2013, 57(10):1473-1482. DOI: 10.1093/cid/cit488.
|
| [6] |
BAKER RJ, MARK PB, PATEL RK, et al. Renal association clinical practice guideline in post-operative care in the kidney transplant recipient[J]. BMC Nephrol, 2017, 18(1):174. DOI: 10.1186/s12882-017-0553-2.
|
| [7] |
TORRE-CISNEROS J, DOBLAS A, AGUADO JM, et al. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish network of infection in transplantation) cohort[J]. Clin Infect Dis, 2009, 48(12):1657-1665. DOI: 10.1086/599035.
|
| [8] |
REIS-SANTOS B, GOMES T, HORTA BL, et al. Tuberculosis prevalence in renal transplant recipients: systematic review and Meta-analysis[J]. J Bras Nefrol, 2013, 35(3):206-213. DOI: 10.5935/0101-2800.20130033.
|
| [9] |
YEHIA BR, BLUMBERG EA. Mycobacterium tuberculosis infection in liver transplantation[J]. Liver Transpl, 2010, 16(10):1129-1135. DOI: 10.1002/lt.22133.
|
| [10] |
SUBRAMANIAN AK, MORRIS MI, AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis infections in solid organ transplantation[J]. Am J Transplant, 2013, 13 (Suppl 4):68-76. DOI: 10.1111/ajt.12100.
|
| [11] |
BUMBACEA D, AREND SM, EYUBOGLU F, et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement[J]. Eur Respir J, 2012, 40(4):990-1013. doi: 10.1183/09031936.00000712
|
| [12] |
SUN HY. Treating tuberculosis in solid organ transplant recipients[J]. Curr Opin Infect Dis, 2014, 27(6):501-505. DOI: 10.1097/QCO.0000000000000102.
|
| [13] |
BOSCH A, VALOUR F, DUMITRESCU O, et al.A practical approach to tuberculosis diagnosis and treatment in liver transplant recipients in a low-prevalence area[J]. Med Mal Infect, 2019, 49(4): 231-240. DOI: 10.1016/j.medmal.2018.11.013.
|
| [14] |
LOPEZ DE CASTILLA D, SCHLUGER NW. Tuberculosis following solid organ transplantation[J]. Transpl Infect Dis, 2010, 12(2):106-112. DOI: 10.1111/j.1399-3062.2009.00475.x.
|
| [15] |
RAFIEI N, WILLIAMS J, MULLEY WR, et al. Mycobacterium tuberculosis: active disease and latent infection in a renal transplant cohort[J]. Nephrology (Carlton), 2019, 24(5):569-574. DOI: 10.1111/nep.13386.
|
| [16] |
KANWAL S, AKHTAR AM, AHMED A. Factors associated with mortality to drug-resistant tuberculosis and their programmatic management in treatment centres of Punjab, Pakistan[J]. J Pak Med Assoc, 2017, 67(6):858-862.
|
| [17] |
ABAD CLR, RAZONABLE RR. Donor derived mycobacterium tuberculosis infection after solid-organ transplantation: a comprehensive review[J]. Transpl Infect Dis, 2018, 20(5): e12971. DOI: 10.1111/tid.12971.
|
| [18] |
WU X, CHEN P, WEI W, et al. Diagnostic value of the interferon-γ release assay for tuberculosis infection in patients with Behçet's disease[J]. BMC Infect Dis, 2019, 19(1):323. DOI: 10.1186/s12879-019-3954-y.
|
| [19] |
HEYMANN WR. The hydroxychloroquine-interferon gamma release assay question: TB or not TB?[J]. J Am Acad Dermatol, 2019, 80(4):902-903. DOI: 10.1016/j.jaad.2019.01.070.
|
| [20] |
BENNET R, NEJAT S, ERIKSSON M. Effective tuberculosis contact investigation using interferon-gamma release assays[J]. Pediatr Infect Dis J, 2019, 38(4):e76-e78. DOI: 10.1097/INF.0000000000002272.
|
| [21] |
KUNIHIRO Y, TANAKA N, KAWANO R, et al. Differential diagnosis of pulmonary infections in immunocompromised patients using high-resolution computed tomography[J]. Eur Radiol, 2019. DOI: 10.1007/s00330-019-06235-3[Epub ahead of print].
|
| [22] |
GIACOMELLI IL, SCHUHMACHER NETO R, NIN CS, et al. High-resolution computed tomography findings of pulmonary tuberculosis in lung transplant recipients[J]. J Bras Pneumol, 2017, 43(4):270-273. DOI: 10.1590/S1806-37562016000000306.
|
| [23] |
SCHUHMACHER NETO R, GIACOMELLI IL, SCHULLER NIN C, et al. High-resolution CT findings of pulmonary tuberculosis in liver transplant patients[J]. Clin Radiol, 2017, 72(10):899.e9-899.e14. DOI: 10.1016/j.crad.2017.05.006.
|
| [24] |
GIACOMELLI IL, SCHUHMACHER NETO R, MARCHIORI E, et al. Chest X-ray and chest CT findings in patients diagnosed with pulmonary tuberculosis following solid organ transplantation: a systematic review[J]. J Bras Pneumol, 2018, 44(2):161-166. DOI: 10.1590/s1806-37562017000000459.
|
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: